poisar

Stocks · News reference

Guggenheim Lowers Price Target on Twist Bioscience

Fiscal.ai

Guggenheim has reduced its price target for Twist Bioscience Corporation from $212 to $150.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading